Literature DB >> 2694622

Update on pseudomembranous colitis.

J Silva.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Homer A. Boushey, MD, Professor of Medicine, under the direction of Lloyd H. Smith, Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2694622      PMCID: PMC1026745     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  35 in total

Review 1.  Disease associated with Clostridium difficile infection.

Authors:  D N Gerding
Journal:  Ann Intern Med       Date:  1989-02-15       Impact factor: 25.391

2.  Drug-induced colitis mimicking an acute surgical condition of the abdomen.

Authors:  F J Tedesco; C B Anderson; W F Ballinger
Journal:  Arch Surg       Date:  1975-05

3.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

4.  Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens.

Authors:  R Fekety; J Silva; C Kauffman; B Buggy; H G Deery
Journal:  Am J Med       Date:  1989-01       Impact factor: 4.965

Review 5.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

6.  Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG.

Authors:  S L Gorbach; T W Chang; B Goldin
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

7.  Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

Authors:  M Tvede; J Rask-Madsen
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

8.  Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.

Authors:  C M Surawicz; G W Elmer; P Speelman; L V McFarland; J Chinn; G van Belle
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

9.  Treatment of Clostridium difficile-associated disease with teicoplanin.

Authors:  F de Lalla; G Privitera; E Rinaldi; G Ortisi; D Santoro; G Rizzardini
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

10.  Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.

Authors:  B P Buggy; R Fekety; J Silva
Journal:  J Clin Gastroenterol       Date:  1987-04       Impact factor: 3.062

View more
  3 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.

Authors:  J A Kink; J A Williams
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature.

Authors:  V Masciullo; S Mainenti; D Lorusso; P A Margariti; G Scambia
Journal:  Obstet Gynecol Int       Date:  2010-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.